• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Sep30
Distribution Plan(EST)

Cash dividend 0.59 USD

Aug23
Distribution Plan(EST)

Cash dividend 0.59 USD

Distribution Plan(EST)

Cash dividend 0.59 USD

View More

Event Tracking

Dec22
Eli Lilly Achieves Breakthrough with Oral Weight-Loss Drug in Maintaining Weight Reduction
00:00
Dec21
US Pharmaceutical Industry Pledges $370 Billion Investment to Expand Manufacturing
20:42
Analyst Comments on Chinese Pharmaceutical Companies' Competitive Strategies in the Hundred-Billion-Dollar Weight-Loss Market
20:11
Sina Finance article discusses the internationalization path for Chinese pharmaceutical companies after Eli Lilly's market cap surpassed one trillion dollars.
18:50
Rumors suggest FDA decision on Eli Lilly's weight-loss pill Orforglipron could come by late March 2026
15:10
Eli Lilly and Company to Participate in the 44th Annual J.P. Morgan Healthcare Conference
15:10